Our strategists estimate that each $50 billion of AI capex, or 1 percentage point change in semiconductor profit margins, in 2028 would shift S&P 500 earnings-per-share (EPS) growth by about 1 percentage point. If consensus S&P 500 EPS estimates fell back to the 30-year trend and the P/E ratio fell to the 30-year average of 17x, the S&P 500 would decline by roughly 25% to a level of approximately 5,600.
In addition, S&P earnings growth and recent stock returns have been highly concentrated in a handful of stocks. As the earnings growth from the AI investment cycle fades, the key question is whether another sufficiently large source of earnings strength will emerge to sustain index-level profits, Snider writes. Some of the dynamics during the late stages of other bull markets—such as Federal Reserve rate hikes—are taking place today.
“One striking contrast with past overextended bull markets is the lack of speculative mania in today’s market,” Snider notes. He points out that recent equity returns have generally tracked near-term earnings outlooks. While active fund managers faced a difficult backdrop in much of 2026, Snider says earnings-driven returns, elevated dispersion, and improving equity market breadth bode well for stock pickers heading into the new year.
What themes are expected to drive US stocks in 2027?
As AI capex decelerates, Snider expects investors to shift their focus to “the next earnings beneficiaries of the AI boom.” For example, cloud-operating hyperscalers have increasingly shown signs of monetization of their AI investments.
Another theme in 2027 may reflect the surge in corporate borrowing that has taken place to fund AI investment. Strong capex has come in part at the expense of buybacks, according to Goldman Sachs Research. That may create opportunities in “buyback aristocrats”—stocks with strong free cash flow generation and a commitment to returning cash to shareholders.
During the past few decades, periods of slowing earnings and economic growth have favored stocks with price momentum, upward earnings revisions, and “quality” attributes such as low volatility and strong balance sheets, Snider writes. He says the information technology and healthcare sectors have a history of outperformance in these situations.
Investors may also benefit from diversifying into defensive stocks, such as consumer staples companies, that tend to deliver stable profits even when the economy slows, according to Snider. “Although our base case is for continued earnings growth and equity market appreciation, the downside risks associated with extended earnings and valuations argue for diversifying portfolios with select defensives,” he writes.
This document has been prepared by the Goldman Sachs Executive Office and is not a product of Goldman Sachs Global Investment Research. The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment, legal, or tax advice, a recommendation from any Goldman Sachs entity to take any particular action or be used as a basis for any other investment decision, or an offer or solicitation to purchase or sell any securities or financial products. Any forward-looking statements, case studies, computations or examples set forth herein are for illustrative purposes only. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any sponsorship, affiliation, endorsement, ownership or license rights between any such company and Goldman Sachs. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs.